Name Patient Programs

Name patient programs provide controlled, pre-approval access to drugs in response to requests by physicians on behalf of specific or “named” patients before those products are approved for marketing in Israel.

The Name Patient procedure became an important element in Reimbursement and Market Access in recent years, and Megapharm has developed expertise in this activity. We have executed dozens of different Name Patient and Early Access programs in Israel throughout recent years.